HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Details Its $1 Billion R&D Investment In 2012 Annual Report

This article was originally published in The Rose Sheet

Executive Summary

L’Oreal’s 2012 Annual Report highlights successful collaborations between the firm’s research and marketing departments, resulting in product innovations that meet unique consumer and regional needs. The French firm boosted its R&D spend in 2012 by 9.7% to reach $1.02 billion.

You may also be interested in...



The Body Shop Buys Majority Stake In Brazilian Beauty Retailer

Pending deal between the Body Shop and Brazilian beauty retailer Emporio Body Store will give the L’Oreal-owned retailer a strong entry point to the booming Brazilian beauty market, it says. Announced Oct. 15, The Body Shop plans to purchase 51% of the company, whose network consists of 130 points of sale in the country.

In Brief

Latest research from Mintel suggests that men ages 18 to 34 are more likely than their female peers to buy personal-care products online. More news in brief.

L'Oreal Banking On “Major” Product Launches In 2012 Second Half

L’Oreal will launch three major new fragrances that will help boost its cosmetics sales beyond the projected growth rate of the overall global cosmetics market this year, firm states in Aug. 29 earnings report. Net operating profit advanced 11.4% to $2.37 billion in first half.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018485

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel